Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: BNGO) | Delayed: 1.13 -0.05 (4.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.18 | 52 Week High | $ | |||
| Open | $1.18 | 52 Week Low | $ | |||
| Day High | $1.18 | P/E | N/A | |||
| Day Low | $1.10 | EPS | $ | |||
| Volume | 250,859 | |||||
